Evidence map›Paper›PMID 32161721›Full record

ArticleFrontiers in oncology

Corrigendum: Ultra-High Dose Rate (FLASH) Radiotherapy: Silver Bullet or Fool's Gold?

Joseph D Wilson, Ester M Hammond, Geoff S Higgins, Kristoffer Petersson

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. FLASH-RT does not affect chromosome translocations and junction structures beyond that of CONV-RT dose-rates.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023
    Article
  7. Article
  8. Charge collection efficiency, underlying recombination mechanisms, and the role of electrode distance of vented ionization chambers under ultra-high dose-per-pulse conditions.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2022
    Article
  9. Review
  10. Article
  11. Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice.Clinical cancer research : an official journal of the American Association for Cancer Research · 2021
    Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Joseph D WilsonDepartment of Oncology, The Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.
Ester M HammondDepartment of Oncology, The Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.
Geoff S HigginsDepartment of Oncology, The Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.
Kristoffer PeterssonDepartment of Oncology, The Oxford Institute for Radiation Oncology, University of Oxford, Oxford, United Kingdom.

Funding

Cancer Research UK 19590Cancer Research UK 28736Medical Research Council MC_UU_00001/9
6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fonc.2019.01563.].

Indexed as

FLASHhypoxiaimmunenormal tissueradiotherapy

Identifiers

PMID32161721
PMCPMC7053480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.